Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?
dc.creator | Shihab, Hasan M | |
dc.creator | Lutwama, Fred | |
dc.creator | Piloya, Theresa | |
dc.creator | Castelnuovo, Barbara | |
dc.creator | Kambugu, Andrew D. | |
dc.creator | Colebunders, Robert | |
dc.date | 2011-12-30T17:53:45Z | |
dc.date | 2011-12-30T17:53:45Z | |
dc.date | 2009-03 | |
dc.date.accessioned | 2018-09-04T12:32:16Z | |
dc.date.available | 2018-09-04T12:32:16Z | |
dc.description | Case report | |
dc.description | A large number of patients are switched to second-line antiretroviral therapy, especially in resource limited settings. Lopinavir/Ritonavir is the main drug used in second-line treatment regimens. We describe a patient attending an HIV treatment centre in Kampala, Uganda, who presented with bilateral non-tender pitting inflammatory edema two weeks after switching to a Lopinavir/Ritonavir-containing second-line treatment regimen. The lack of an alternate explanation led us to suspect that Lopinavir/Ritonavir was potentially responsible for the edema | |
dc.identifier | Shihab, H.M., Lutwama, F., Piloya, T., Castelnuovo, B., Kambugu, A.D., Colebunders, R. (2009). Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause? Journal of Infection in Developing Countries, 3(5) | |
dc.identifier | 2036-6590 | |
dc.identifier | http://hdl.handle.net/10570/276 | |
dc.identifier.uri | http://hdl.handle.net/10570/276 | |
dc.language | en | |
dc.publisher | Open Learning on Enteric Pathogens | |
dc.subject | Edema | |
dc.subject | Lopinavir/Ritonavir | |
dc.subject | Resource-limited settings | |
dc.subject | HIV/AIDS | |
dc.subject | Uganda | |
dc.subject | Antiretroviral therapy | |
dc.title | Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause? | |
dc.type | Journal article, peer reviewed |